The Global Pharmaceutical Lipids Market Size was valued at USD 4,198 Million in 2021 and is predicted to be worth USD 6,617 Million by 2030, with a CAGR of 5.4% from 2022 to 2030.
Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. The most important function of lipids is to play as cell membrane transport agents in cell membrane.
|Pharmaceutical Lipids Market
|Market Size 2021
|USD 4,198 Million
|Market Forecast 2030
|USD 6,617 Million
|CAGR During 2022 - 2030
|2018 - 2030
|2022 - 2030
|By Product, By Form, By Source, By Application, And By Geography
|North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|Key Companies Profiled
|ABITEC Corporation, Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company, and Evonik Industries AG
|Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
10 hrs of free customization and expert consultation
Pharmaceutical Lipids Market Dynamics
Pharmaceutical sector across the globe is witnessing rapid growth. With the rising investment in the sector and high R&D activities taking place across developed and developing countries for new drug development. The industry is observing high growth. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct over half the world's R&D in pharmaceuticals US$ 75 Bn and hold the intellectual property rights on most new medicines. Lipids are widely used as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients for delivery of drugs. Flourishing cosmetic sector across the globe and high demand from cosmetic sector for lipid solutions as ingredients are major factors expected to drive the growth of global pharmaceutical lipids market. Major players are investing high for product development activities their approach towards enhancing the business through product launch and acquisition is expected to augment the growth of global pharmaceutical lipids market.
Covid-19 pandemic on its peak and high investment form public and private players for development of vaccines is resulting in players approach towards ramping up the production of lipids to care the growing needs. This is expected to impact the growth of target market. In 2021, MilliporeSigma, a global manufacturer of lipids increased its production capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster. MilliporeSigma is collaborating with more than 50 companies to support their efforts in the development and production of Covid-19 vaccines and treatments, providing custom lipids, as well as other critical raw materials, processing equipment and services used in mRNA drugs and vaccines manufacturing. Factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global pharmaceutical lipids market. In addition, lack of developed infrastructure in developing countries is expected to limit the R&D activities further challenging the growth of target market. However, increasing government spending on development of healthcare sector and introduction of new products are factors expected to create new opportunities for players operating in the pharmaceutical lipids market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.
Pharmaceutical Lipids Market Segmentation
The global pharmaceutical lipids market is segmented into product, form, source and application. The product segment is divided into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others. Among product the triglycerides segment is expected to account for major revenue share in the global pharmaceutical lipids market. The application segment is divided into conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-microemulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and others. The form segment is further segmented into liquid pharmaceutical lipids, semi-solid pharmaceutical lipids, and solid pharmaceutical lipids. The source segment is categorized into synthetic pharmaceutical lipids, semi-synthetic pharmaceutical lipids, and natural pharmaceutical lipids.
Market by Product
Market by Form
Market by Source
Market by Application
Pharmaceutical Lipids Market Regional Outlook
The Middle East & Africa (MEA)
The market in North America is expected to account for major revenue share in the global pharmaceutical lipids market due to high government spending on drug development. Availability of advanced infrastructure for R&D activities and presence of large number of players operating in the country are factors expected to support the market growth. In addition, major players approach towards business expansion through acquisitions is expected to boost the market growth.
Pharmaceutical Lipids Market Players
The global pharmaceutical lipids market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Some of the prominent global pharmaceutical lipids market companies are ABITEC Corporation, Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company, and Evonik Industries AG.
The global pharmaceutical lipids market size in 2021 was accounted to be USD 4,198 Million.
The projected CAGR of pharmaceutical lipids during the analysis period of 2022 to 2030 is 5.4%.
The prominent players of the global pharmaceutical lipids market involve ABITEC Corporation, Nippon Oil & Fats Corporation, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., BASF SE, Dishman Group, Cayman Chemical Company, CordenPharma, Croda International Plc, Gattefossé, IOI Oleo GmbH, Merck KGaA, Stepan Company, and Evonik Industries AG
North America held the dominating share for pharmaceutical lipids during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for Pharmaceutical Lipids during the analysis period of 2022 to 2030.
Increased occurrences of diseases such as cancer and neurological disorders, as well as expansion of the clinical research industry for drug discovery are the prominent factors that fuel the growth of global pharmaceutical lipids market.
Based on product, triglycerides segment held the maximum share for pharmaceutical lipids market in 2021.